Hepatorenal Syndrome (HRS) generally develops in patients with advanced liver disease and may present with gradual or rapidly progressive deterioration in renal function.
The clinical manifestations are related to both hepatic decompensation and impaired kidney function.
1. Oliguria
Oliguria is a common manifestation of significant renal dysfunction and refers to reduced urine output. It may occur because of decreased renal perfusion and reduced GFR.
However, oliguria is not essential for diagnosing HRS-AKI, as serum creatinine changes may precede substantial reductions in urine output.
2. Ascites
Ascites is the accumulation of fluid within the peritoneal cavity. It results from portal hypertension, sodium retention, and increased fluid movement into the abdominal cavity.
Patients with HRS frequently have severe or refractory ascites.
3. Peripheral edema
Fluid retention may cause bilateral lower-limb edema, particularly in patients with advanced hepatic dysfunction and hypoalbuminemia.
4. Fatigue and generalized weakness
Patients may experience persistent fatigue, reduced physical activity, and generalized weakness due to hepatic dysfunction, renal impairment, electrolyte disturbances, and systemic inflammation.
5. Jaundice
Jaundice occurs because of impaired hepatic bilirubin metabolism and excretion. It is a common feature of advanced liver disease but is not specific to HRS.
6. Hepatic encephalopathy
Patients may develop confusion, altered consciousness, disorientation, and, in severe cases, coma due to impaired hepatic detoxification and accumulation of neurotoxic substances.
7. Fluid overload and respiratory symptoms
Severe sodium and water retention may cause pulmonary congestion, pleural effusions, and respiratory difficulty, particularly when renal dysfunction is advanced.
4.2 Laboratory findings
Laboratory investigations play an important role in evaluating renal dysfunction, identifying precipitating conditions, and excluding alternative causes.
Investigation Typical findings or significance
Serum creatinine Increased
Blood urea nitrogen Frequently increased
Estimated GFR Reduced, although creatinine-based estimates may be inaccurate in cirrhosis
Serum sodium May be reduced due to dilutional hyponatremia
Serum potassium May be increased, particularly in advanced renal dysfunction
Serum albumin Frequently reduced due to impaired hepatic synthesis and other factors
Serum bilirubin Often elevated due to hepatic dysfunction
Urinalysis May be relatively bland, although abnormalities do not exclude HRS
Urine sodium Frequently low, but not reliable as a standalone diagnostic test
Urine osmolality May be relatively high because of ADH-mediated water retention
It is important to recognize that serum creatinine may underestimate the severity of renal dysfunction in patients with cirrhosis because of reduced muscle mass, impaired hepatic creatine synthesis, and altered creatinine production.
4.3 Diagnostic criteria for HRS-AKI
The 2024 joint consensus recommendations of the Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) provide updated diagnostic criteria for HRS-AKI.
The diagnosis requires the following:
1. Underlying cirrhosis with ascites.
2. Evidence of acute kidney injury, defined by one or both of the following:
- Increase in serum creatinine of at least 0.3 mg/dL (26.5 µmol/L) within 48 hours.
- Increase in serum creatinine of at least 50% from baseline, known or presumed to have occurred within the preceding seven days.
Alternatively, urine output of 0.5 mL/kg/hour or less for at least six hours may establish AKI.
3. No improvement in serum creatinine and/or urine output within 24 hours following adequate volume resuscitation, when clinically indicated.
4. Absence of strong evidence for an alternative explanation as the primary cause of AKI.
An important change in the 2024 consensus is that a mandatory 48-hour albumin administration period is no longer required before diagnosing HRS-AKI. This helps avoid unnecessary delays in treatment and prevents inappropriate albumin administration in patients who are already volume overloaded.
4.4 Classification of HRS
Contemporary terminology classifies HRS according to the duration and nature of kidney dysfunction.
Classification Description
HRS-AKI Hepatorenal syndrome associated with acute kidney injury
HRS-AKD Hepatorenal syndrome associated with acute kidney disease lasting less than 90 days
HRS-CKD Hepatorenal syndrome associated with chronic kidney disease lasting more than 90 days
The previous type 1 and type 2 classifications are largely historical and have been replaced by this newer framework.
4.5 Differential diagnosis
HRS must be differentiated from other causes of renal dysfunction in patients with liver disease.
Important differential diagnoses include:
- Acute tubular injury or necrosis.
- Pre-renal AKI due to dehydration or hemorrhage.
- Sepsis-associated AKI.
- Drug-induced nephrotoxicity.
- Glomerulonephritis.
- Acute interstitial nephritis.
- Urinary tract obstruction.
- Pre-existing chronic kidney disease.
Urinalysis, urine microscopy, renal ultrasonography, clinical assessment, and selected kidney injury biomarkers may help distinguish these conditions.
However, HRS can coexist with tubular injury or chronic kidney disease; therefore, the presence of some structural abnormalities does not automatically exclude HRS.
4.6 Additional investigations
The following investigations may be useful:
- Complete blood count to identify infection, anemia, and thrombocytopenia.
- Liver function tests to assess hepatic impairment.
- Coagulation profile, particularly prothrombin time and INR.
- Blood and urine cultures when infection is suspected.
- Diagnostic paracentesis to evaluate for spontaneous bacterial peritonitis.
- Renal ultrasonography to exclude obstruction and assess renal anatomy.
- Electrocardiography when electrolyte disturbances are suspected.
- Chest radiography and oxygenation assessment when fluid overload or respiratory complications are present.
Clinical importance: Early identification of HRS-AKI is particularly important because treatment response is generally more favorable when therapy is initiated before severe and prolonged renal impairment develops.
Medical Disclaimer: The information provided in this article is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any medical decisions or starting, changing, or stopping any treatment. Do not ignore or delay seeking medical advice based on information published on this blog.
CONTINUE READING
Hepatorenal Syndrome: Management
No comments:
Post a Comment